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CH2==CHCH2 or C6HsCH2. Such compositions exhibit 
activity as anticancer agents. 
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1 
HETEROAROTINOID COMPOUNDS AS 
ANTICANCER AGENTS 
This is a continuation-in-part of co-pending applica- 5 
tion Ser. No. 598,482 filed on Apr. 9, 1984, now aban-
doned. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 10 
This invention relates to anticancer compositions. 
More specifically, the invention relates to certain 4-[3,4-
dihydro-4,4-dimethyl-2H-l-benzoheterapyran-6-yl)-1-
propenyl]benzoates and derivatives thereof. 
2. Description of the Prior Art 15 
To the best knowledge of the inventors, the title 
compounds have not been reported in the literature but 
certain hydrocarbon counterparts are documented. 
Such hydrocarbon systems have been referred to as 
arotinoids and several papers on the subject have been 20 
published, such as in the European Journal of Medicinal 
Chemistry, 1980, Vol. 15, pages 9-15, entitled "Aroti-
noids, A New Class of Highly Active Retinoids" by P. 
Loeliger, W. Bollag and H. Mayer. Synthesis and ste-
reochemistry are discussed. A second more recent pub- 25 
lication has peripherally related derivatives and is enti-
tled "Fluorinated Retinoic Acids and Their Ana-
logues". 3. Synthesis and Biological Acitivity of Aro-
matic 6-Fluoro Analogues" by A. J. Lovey and B. A. 
Pawson. The article appeared in the Journal of Medici- 30 
nal Chemistry, Vol. 25, pages 71-75 (1982). A review of 
the entire area of biological activity of retinoids and 
related compounds has been published in the Journal of 
Medicinal Chemistry, Vol. 25, pages 1269-1277 (1982). 
The title is "Retinoids at the Threshold: Their Biologi- 35 
cal Significance and Therapeutic Potential", by B. A. 
Pawson, C. W. Ehmann, L. M. Itri, and M. I. Sherman. 
The first paper contains work which is the most closely 
related to the compounds cited in this application in 
terms of preparation from ketones and conversion to the 40 
final product through a type of Wittig reaction. In no 
case, however, was a heteroatom ever involved in the 
ring systems employed and it is felt that the presence of 
the heteroatom makes a significant difference in the 
properties of the heteroarotinoids described and 45 
claimed herein. 
According to the existing literature~ some derivatives 
of the arotinoids have been found to possess useful bio-
logical activities. One type of test for therapeutic po-
tency is the antipapilloma test (cited in the first article 50 
above) and the tracheal organ culture assay which is 
described in an article in the Journal of Cancer Research, 
Vol. 40, 3413-3425 (1980) by D. L. Newton, W. R. 
Henderson, and M. B. Sporn. The assays assess the 
ability of the test compound to prevent skin papillomas 55 
and carcinomas in mice or to prevent keratinization of 
cultured tracheal cells which frequently occurs when 
cells become premalignant. Further evidence on these 
points can be found in articles in entitled "Chemopre-
vention of Cancer with Retinoids" by M. B. Sporn and 60 
D. L. Newton, published in the Federation Proceedings, 
Vol. 38, pages 2528-2534 (1979) and "Structure-
Activity Relationships of Retinoids in Hamster Trach-
eal Organ Culture" by D. L. Newton, W.R. Hender-
son, and M. B. Sporn, published in Cancer Research, 65 
Vol. 40, pages 3414-3425 (1980). Another test for po-
tential anticancer activity of retinoic acid derivatives 
has been the ornithine decarboxylase assay which has 
2 
been reviewed recently in connection with an evalua-
tion of some aromatic retinoic acid compounds. The 
article is entitled "Aromatic Retinoic Acid Analogues. 
2. Synthesis and Pharmacological Activity" by M. I. 
Dawson, R. Chan, P. D. Hobbs, W. Chao, and L. J. 
Schiff and was published in the Journal of Medicinal 
Chemistry, Vol. 26, pages 1282-1293 (1983). The com-
pounds of the present inventions were assayed using the 
tracheal organ culture procedure. 
The present invention novel (E)- and [(Z)]-4-[2-(3,4-
dihydro-4,4-dimethyl-2H-l-benzoheterapyran-6-yl)-l-
propenyl]benzoate and derivative compositions charac-
terized by the formulae: 
and 
where R is H, CH3, or C2Hs and where Xis S,S-O,O,-
N-CH3, Si(CH3)2, N +(H)CH3[Cl-], 
N +(H)CH3[Br-], N +(alkyl)CH3[Br-] and where alkyl 
is CH3, C2Hs, CH2=CHCH2, or C6HsCH2; and the 
corresponding five-membered ring systems character-
ized by the formula: 
and 
where R is H, CH3, or C2Hs and where X is 
s,s-o,o,N,-CH3, Si(CH3)2, N+(H)CH3(Cl-] or 
N+(H)CH3[Br-] or N-(H)CH3[Cl-], 
N+(H)CH3[Br-], N+(alkyl)CH3[Cl-] or N+(al-
kyl)CH3[Br-] and where alkyl is CH3, C2Hs, 
CH2=CHCH2 or C6HsCH2. 
It is an object of the present invention to provide 
novel heteroarotinoids which are structurally related to 
4,826,984 
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ble according to the present invention to replace part of 
the backbone of the retinoic acid skeletal chain with a 
phenyl group. In addition, the present invention has 
all trans-retinoic acid and which act as anticancer 
agents for the treatment of skin disorders and tumors. 
Fulfillment of this object and the presence and fulfill-
ment of other objects will be apparent upon complete 
reading of the specification and claims. 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENT 
5 been able to block or retard oxidation of the ring double 
bond in retinoic acid by the introduction of an aryl 
group. Also, the heteroatom has, advantageously, re-
placed the methylene group at the C(4) position of the 
The novel heteroarotinoid compositions according to 
the preferred embodiments of the present invention are 10 
heteronuclear rings, organic compounds based upon the 
generic structures designated below as compounds (1), 
(2), (3) and (4). The !-position is occupied by the hetero-
atom such as O,S,S-O,N-alkyl or Si(CH3)2 (for pur-
poses of this invention the heteroatom is symbolized by 15 
X in the formulae). The R symbolizes a -H, methyl or 
ethyl group. These heteroarotinoids are structurally 
related to all trans-retinoic acid which in tum is known 
to possess certain anticancer properties; however, they 
are structurally unique in that they possess a hetero- 20 
atom. As exemplified later, the compositions of the 
present invention exhibit good activity with respect to 
the reversal of keratinization in the tracheal organ cul-
ture assay when compared with the standard all trans-
retinoic acid. Furthermore, they appear to be less toxic 
25 
than the standard. 
PRODUCTS 
(I) 
retinoic acid structure which is known to undergo oxi-
dation, via metabolic degradation in cell lines. As men-
tioned above and as exemplified later, preliminary toxic-
ity data indicate that the tracheal cell lines (screening 
profile using cell culture lines from hamsters with all 
trans-retinoic acid as the standard) do not slough off as 
has been experienced with more toxic agents. Thus, it is 
felt that the reduced toxicity effects being obseved in 
the heteroarotinoids of the present invention can be 
attributed, in part, to the presence of the heteroatom 
and perhaps this in tum can be explained or rational-
ized, at least in part, by the enhanced polar character 
and reduced lipophlicity relative to all trans-retinoic 
acid associated with the presence heteroatom. The pres-
ence of the heteroatom should also markedly improve 
the water solubility of the heteroarotinoids and im-
proved drug transport. Thus the compositions accord-
ing to the present invention are potential drugs for use 









Typically, the compounds according to the present 
invention are synthesized by one or the other of the 
35 following generalized reaction schemes which initially 
involve synthesis of key starting materials ketone 5 and 
ester-aldehyde 6 (underlined numerals as used herein 
correspond to numerically identified formulae). The 
40 
45 
remaining steps of the respective reaction schemes I and 
II involve the combining of reactants 5 and 6 to com-
plete the overall synthesis of the desired heteroaroti-
noids 1, 2, 3, or 4 as previously shown. The respective 
reaction schemes I and II correspond to the synthesis of 
the "2H-l-benzoheterapyran-6-yl" and the correspond-
ing "2H-l-benzohe~erafuran" structures, respectively. 
The formation of the heterocyclic ketone 5 and the 
corresponding five-membered heterocyclic ketone 18 is 
50 felt to be crucial and novel in that no counterpart to the 







The new methodology and synthesis of the present 65 
invention permits the introduction of selected heteroat-
oms as replacements for methylene groups within the 
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decanted, and the residue was washed with dry ether 
(3 X 50 mL). The combined organics were dried (Na2. 
SO4), and the ether was removed (vacuum). Vacuum 
distillation of the crude oil gave 14.95 g (80.3%) com-
5 pound 8 as a colorless liquid: bp 93° -98° C./0.01 mm 
(literature reports 110° -113 • C./0. 7 mm, see F. Mon-
tanari, R. Daniel, H. Hogeveen, and G. Maccagnani, 
Tetrahedron Letters, 2685 (1964); IR (neat) 3200-3600 
cm-1 (OH); lH NMR (DCCl3)81.17 [s, 6H, (CH3)2], 
10 1.66-1.84 [m, 2H, ArSCH2CH2], 2.38-2.47 [br s, IH, 
OH], 2.88-305 [m, 2H, ArSCH2], 7.04-7.34 [m, 5H, 
Ar-H]; 13C NMR (DCCb) ppm 28.2 [SCH2], 28.9 
[CH3], 42.4 [SCH2CH2], 70.2 [C-OH]; Ar-C [125.3, 
(19) 
15 128.2, 128.4, 136.1]. 
I. !!-BuLi/hexane 
4,4-Dimethylthiochroman or 
3,4-Dihydro-4,4-dimethyl-2H-1 benzothiopyran (9) 
(X=S) 
20 A mixture of 2-methyl-4-(phenylthio)-2-butanol 
(compound 8 above, 10.0 g, 0.051 mol), H3PO4 (85%, 5 
mL) and benzene (50 mL) were heated to reflux under 
N2 with vigorous stirring for 24 hours. During this 
period, P2Os (3 X 6.0 g, 0.126 mol) was added in three 
(3) + (4) 25 equal portions at 6 to 8 hour intervals. After cooling, 
the solution was decanted from the reddish-purple resi-
due, and the residue was washed with ether (2 x 25 
ML). The combined orgaics were washed with 5% 
In order to further illustrate the general synthesis of 
the heteroarotinoids according to the present invention; 
their respective preparation and isolation as a purified 
biologically active heterocycle; and their activity in the 
tracheal organ assay, the following sequence of exam- 30 
pies was performed. 
EXAMPLE I 
aqueous NaHCO3 (2X50 mL) and saturated aqueous 
NaCl (3 X 50 mL). After drying (Na2SO4) the solution, 
the solvent was removed, and the residual oil was vac-
uum distilled to give 7.4 g (81.5%) of compound 9 as a 
colorless liquid: bp 80°-85° C./0.01 mm; 1H NMR 
(DCCb) 81.29 [s, 6H, (CH3)2], 1.84-1.97 [m, 2H, H(3)], Prepartion of Ethyl 3-(Phenylthio)propionate (7) 
(X=S) 
Freshly distilled ethyl acrylate (75 mL) was added 
dropwise under N2 to a stirred, ice-cold mixture of 
thiophenol (31.5 g, 0.286 mol) and sodium ethoxide (1.0 
35 2.91-3.03 [m, 2H, H(2)], 6.9-7.35 [m, 4H, Ar-H]; 13C 
NMR (DCCb) ppm 23.1 [SCH2], 30.2 [CH3], 32.9 
[(CH3)2C], 37.7 [SCH2CH2]; Ar-C [123.8, 125.8, 
126.26, 126.3, 131.5 [C(4a)], 141.7 [C(8a)]]. 
g). The ice bath was removed, and the mixture was 
stirred at room temperature for 24 hours. The mixture 40 
was diluted with ether (30 mL) and filtered. The ether 
and and excess ethyl acrylate were removed (vacuum). 
Vacuum distillation gave 49.6 g (82.6%) of compound 7 
as a colorless liquid: bp 115° -118° C./0.2 mm (literature 
reports 117° C./2.5 mm; see K. Iwai, H. Kosugi, A. 45 
Miyazaki, and H. Uda, Synthetic Communications, 6, 357 
(1976); IR (neat) 1730-1750 cm-1 (C=O); IH NMR 
(DCCb)81.22 (t, 3H, OCH2CH3), 2.58 (t, 2H, 
CH2CO2C2Hs) 3.14 (t, 2H, SCH2), 4.1 (q, 2H, 
OCH2CH3), 7.07-7.37 (m, 5H, Ar-H); 13C NMR 50 
(DCCl3) ppm 14.2 [OCH2CH3], [SCH2], 34.4 
[CH2CO2], 60.5 [OCH2CH3]; Ar-C [126.3, 128.8, 
129.8, 135.2 ], 171.3 [C=O]. 
Both hydrogen and carbon-13 NMR spectral shifts 
were measured from tetramethylsilane (TMS) standard 55 
on a Varian XL-100(15) or XL-300 spectrometer con-
firming the correct hydrogen distribution and carbon 
atom assignments. 
2-Methyl-4-(phenylthio)-2-butanol (8) (X=S) 60 
A solution of ethyl 3-(phenylthio)propionate (com-
pound 7above; 20.0 g, 0.095 mol) in dry ether (5 mL) 
was added under N2 to a stirred solution of methylmag-
nesium chloride in THF (2.9M, 105 mL, 0.304 mol) at a 
rate such that the solution boiled. The solution was then 65 
heated at reflux for an additional 36 hours. The mixture 
was cooled to room temperature and quenched with 
saturated aqueous NH4Cl. The supemant liquid was 
4,4-Dimethylthiochroman-6-yl Methyl Ketone or 
1-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-
yl)ethanone (5) (X=S) 
Stannic chloride ( 4. 7 mL, 0.050 mol) was added drop-
wise under N2 to a stirred solution of 4,4-dimenthylthio-
chroman (compound 9 above; 6.6 g, 0.037 mol) and 
acetyl chloride (3.1 g, 0.039 mol) in dry, thiophene-free 
benzene (30 mL). The resulting dark green solution was 
stirred at room temperature for 5 hours and then diluted 
with water (30 mL) and concentrated HCI (15 mL). The 
resulting mixture was heated to just below the boiling 
point for 15 minutes. The mixture was allowed to cool 
to room temperature, and the two layers were sepa-
rated. The aqueous layer was extracted with benzene 
(5X20 mL), 5% aqueous Na2CO3 (2X40 mL), H2O (50 
mL), and brine (60 mL). After drying (Na2SO4) the 
solution, the solvent was removed (vacuum) leaving a 
viscous brown oil. Vacuum distillation gave 4.92 g 
(60.4%) of compound 5 as a pale yellow oil: bp 
126°-130° C./0.02 mm; IR (neat) 1675-1685 cm-1 
(C=O); IH NMR (DCCl3)81.32 [s, 6H, (CH3)2], 
1.84-1.97 [m, 2H, H(3)], 2.51 [s, 3H, CH3C=O], 
2.95-3.07 [m, 2H, H(2)], 7.07 [d, IH, J = 8 Hz, H(8)], 
7.35 [dd, lH, J =2 Hz, J =8 Hz, H(7)], 7.95 [d, lH, J =2 
Hz, H(5)]; 13C NMR (DCCl3) ppm 23.1 [SCH2], 26.2 
[H3CC=O], 29.7 [C(CH3)2], 32.9 [(CH3)2C], 36.8 
[SCH2CH2]; Ar-C [125.7, 126.1, 132.8, 139.3, 141.6], 
196.7 [C=O]; Mass spectral data for compound 5; 
4,826,984 
10 9 
C13H16OS: m/e (M+) 220.0922 theoretical; Found: 
220.0922. 
Ethyl 4-Formylbenzoate (6) 
A solution of ethyl p-toluate (compound 10; 6.0 g, 5 
0.037 mol; prepared from p-toluic acid and ethanol by 
conventional techniques), glacial acetic acid (57 mL), 
and acetic anhydride (57 mL) in a flask equipped with a 
thermometer and a mechanical stirrer was cooled to o• 
to 5° C. in an ice-salt bath. Concentrated H2SO4 (8.5 10 
mL) was added slowly to the stirred solution. Chro-
mium trioxide (10.0 g, 0.10 mol) was added in small 
portions over a period of 25 minutes. The temperature 
[C(9)], 123.2, 123.6, 126.6, 130.7, 141.6, 142.9. The mate-
rial was used without further purification. 
[ 1-( 4,4-Dimethylthiochroman-6-yl)ethyl]tripheny lphos-
phonium Bromide or 
[1-(3,4-dihydro-4,4-dimethyl-2H-l-benzothiopyran-6-
yl)ethyl]triphenylphosphonium Bromide (13) (X=S) 
A solution of the alcohol 12 (0.5 g, 2.25 mmol) and 
triphenylphosphine hydrobromide (0. 78 g, 2.27 mmol) 
in CH3OH (20 mL) was stirred at room temperature 
under N2 for 26 hours. Removal of the solvent left a 
yellow oil which solidified after repeated trituration 
with dry ether. The resulting powder was stirred in dry 
ether (30 mL) for 8 hours, filtered, and dried (110° C./2 
mm) to give 0.9 g (73.1%) of compound 13 as a tan 
powder; mp 139°-145° C. (dee); 1H NMR (DCCh) 1.07 
[s, 3H, CH3], 1.15 [s, 3H, CH3], 1.75 [d, 3H, CHCH3], 
1.80-1.88 [m, 2H, H(3)], 2.96-3.02 [m, 2H, H(2)], 
6.40-6.55 [m, lH, CHP(C6Hs)3], 6.58 [dd, lH, H(7)], 
6.86 [d, lH, H(8)], 7.45 [br s, lH, H(5)], 7.62-7.90 [m, 
15H, P+(C6Hs)3]. The salt was used without further 
purification. 
of the mixture was maintained below 5° C. at all times. 
After stirring at o• to 5° C. for an additional 20 minutes, 15 
the mixture was poured into a breaker (i full) with ice. 
Cold water was then added to bring the total volume to 
600 mL. The resulting dark green-brown mixture was 
extracted with ether (3X250 mL), and the organic lay-
ers were combined. The organic layer was washed with 20 
water (3X200 mL), 5% aqueous Na2CO3 (2X200 mL), 
and brine (200 mL). After drying (Na2SO4) the solution, 
the solvent was removed leaving the diacetate 11 as a 
pale yellow liquid. A mixture of the crude diacetate 11, Ethyl 
concentrated H2so4 (2 mL), water (20 mL), and 95% 25 (E)-p-[2-(4,4-Dimethylthiochroman-6-yl)propenyl]ben-
ethanol (20 mL) was heated at reflux under N2 for 45 zoate or Ethyl 
minutes. The solution was allowed to cool to room (E)-4-[2-(3,4-dihydro-4,4-dimethyl-2H-l-benzothiopy-
temperature. After diluting the solution with water (40 ran-6-yl)-l-propenyl]benzoate (X=S) 
mL), the resulting mixture extracted with ether (3X40 A solution of n-butyllithium in hexane (1.55M, 1.3 
mL). The combined organic layers were washed with 30 mL, 2.01 mmol) was added dropwise under N2 to a 
5% aqueous NaHCO3 (2X50 mL) and water (50 mL). stirred suspension of the phosphonium salt 13 (1.1 g, 
After drying (Na2SO4) the solution, the solvent was 2.01 mmol) in dry ether (30 mL). The resulting dark red 
removed leaving a yellow liquid. Vacuum distillation mixture was stirred for 5 minutes. A solution of the 
gave 3.1 g (47.1 %) of compound 6 as a colorless liquid: freshly distilled aldehyde 6 (9.40 g, 2.25 mmol) in dry 
bp 80°-84° C./0.05 mm (literature reports 142° C./13 35 ether (15 mL) was then added all at once. The mixture 
mm; see K. H. Slotta and R. Kethur, Ber. 71, 335 became creamy yellow and then cream-colored, and a 
[1938]); IR (neat) 1705-1735 cm-I (C=O): 1H NMR large amount of off-white solid precipitated. After stir-
(DCCh) 61.42 [t, 3H, OCH2CH3], 4.41 [q, 2H, ring at room temperature for 36 hours, the mixture was 
OCH2CH3], 7.87-8.22 [pseudo q, 4H, Ar-H], 10.08 [br filtered. The solid was washed with ether (50 mL). The 
s, lH, CHO]; 13C NMR (DCCh) ppm 14.2 [OCH2CH3], 40 combined filtrates were concentrated to give a yellow 
61.4 [OCH2CH3]; Ar-C [129.2, 129.9, 135.2, 138.9], oil which was dissolved in warm 95% ethanol (50 mL). 
165.2 [C02C2Hs], 191.2 (CHO). The resulting solution was filtered and then concen-
6,4,4-Trimethylthiochroman-6-methanol or 
3,3-Dihydro-6,4,4-trimethyl-2H-l-benzothiopyran-6- 45 
methanol (12) (X=S) 
A solution of 4,4-dimethylthiochroman-6-yl methyl 
ketone (compound 5 above; 4.0 g, 0.018 mol) in dry 
ether (20 mL) was added dropwise under N2 to a stirred 
suspension of LiAlff4 (1.0 g, 0.026 mol) in ether (75 50 
mL). The resulting mixture was heated at reflux for 24 
hours. Ethyl acetate was then added dropwise to de-
stroy the excess LiAlH4. A solution of 5% HCl (50 mL) 
was added, and the mixture was stirred for 10 minutes. 
The layers were separated, and the aqueous layer was 55 
extracted with ether (2X30 mL). The combined or-
ganic layers were washed with 5% aqueous Na2CO3 
(2X50 mL) and brine (2X50 mL). After drying (Na2. 
SO4) the solution, the solvent was removed leaving 3.8 
g (95%) of compound 12 as a colorless oil. Crystalliza- 60 
tion (hex ne) with cooling too• C. gave a white granular 
powder: IR (melt) 3120-:3640 cm-I (OH); -H NMR 
(DCCh)61.3 [s, 6H, (CH3)2], 1.39 [d, 3H, H3 CHOH], 
1.84-2.0 [m, 2H, SCH2CH2], 2.74-2.86 [br s, lH, OH], 
2.9-3.06 [m, 2H, SCH2] 4.71 [q, lH, CH3CHOH], 65 
6.94-7.02 [m, 2H, Ar-H], 7.30-7.36 [m, lH, Ar-H]; 
13C NMR (DCCh) ppm 23.0 [SCH2], 25.0 [H3CCOH], 
30.2 [(H3C)2C], 33.1 [(H3C)2C], 37.7 [SCH2CH2], 70.2 
trated to 10 mL. After cooling slowly to room tempera-
ture, the resulting solid was filtered and washed with 
cold 95% ethanol. After drying in the air, 0.30 g 
(40.7%) of the compound (X=S) was obtained as a 
white solid: mp 92°-93° C.; IR (KBr) 1710-1725 cm- 1 
(C=O); IH NMR (DCCl3) 61.38 [s, 6H, (CH3)2], 1.41 
[t, 3H, OCH2CH3], 1.96-2.02 [m, 2H, SCH2CH2], 2.28 
[s, 3H, CH=C-CH3], 3.04-3.09 [m, 2H, SCH2], 4.4 [q, 
2H, OCH2], 6.82 [s, lH, C=CH], 7.11 [d, lH, J=9 Hz, 
H(8)], 7.21-7.28 [m, lH, H(7)], 7.44 [d, 2H, Ar-H], 7.54 
[s, lH, H(5)], 8.07 [d, 2H, Ar-H]; Mass spectral data 





yl)propenyl]benzoate or Ethyl 
(E)-4-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopy-
ran-1-oxo-6-yl)- l-propenyl]benzoate (X=S--0) 
A solution of Nal04 (0.14 g, 0.65 mmol) in H2O (1 
mL) was added in one portion under N2 to a stirred 
suspension of the compound of Example I (X=S) (0.118 
g, 0.322 mmol) in methanol (10 mL). The mixture was 
stirred at room temperature for an additional 36 hours. 
4,826,984 
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A large amount of white solid precipitated during this 
time. The mixture was concentrated. The residue was 
dissolved in HCCl3 (20 mL) and then filtered and con-
centrated. The resulting oil was triturated with cold 
hexane to induce crystallization. Recrystallization (hex- 5 
ane) gave 55 mg (44.7%) of the compound (X=S.....0) 
as a white powder: mp 91 °-93° C.; IR (KBr) 1700-1715 
(C=O), 1030-1040 cm-1 (S->-O); IH NMR (DCCl3) 
1.37 [s, 3H, CH3], 1.41 [t, 3H, OCH2CH3], 1.51 [s, 3H, 10 
CH3], 1.84-1.94 [m, 1H H(3)], 2.30 [s, 3H, 
CH=C(CH3], 2.48-2.60 [m, lH, H(3)], 3.08-3.23 [m, 
2H, H(2)], 4.41 [q, 2H, OCH2CH3], 7.46 [d, 2H, Ar-H], 
7.51 [dd, J=9 Hz, J=3 Hz, lH, H(7)], 7.58 [d, J=3 Hz, 
lH, H(S)], 7.77 [d, J =9 Hz, lH, H(8)], 8.09 [d, 2H, 15 
Ar-H]; Mass spectral data for C23H26O3S: m/e (M+) 
theoretical 382.1603; Found: 382.1595. 
EXAMPLE III 
4,4-Dimethylchroman or 
3,4-Dihydro-4,4-dimethyl-2H-1-benzopyran (9) (X=O) 
A solution of 2-methyl-4-phenoxy-2-butanol (8, 
X=O, 7.8 g, 0.043 mol) in nitromethane (50 mL) was 
added dropwise under N2 to a stirred suspension of 
anhydrous A!Cl3 (7.8 g, 0.058 mo!) in nitromethane (30 
mL). After stirring at room temperature for an addi-
tional 24 hours, a solution of 6N HCI (80 mL) was 
added slowly. The resulting mixture was stirred for 10 
minutes and diluted with ether (5 mL). The layers were 
separated, and the organic layer was washed with H2O 
(SO mL), saturated aqueous NaHCO3 (4XS0 mL), H2O 
(SO mL), and brine (4XS0 mL). After drying (Na2SO4) 
the solution, the solvent was removed. Vacuum distilla-
tion of the resulting dark brown oil gave 4.35 g (62%) of 
compound 9 (X=O) as a colorless liquid: bp 74°-80° 
C./0.7 mm (literature reports 93+ C./10 mm; see J. 
Colonge, E. Le Sech, and R. Marey, Bull Soc. Chim. 
Methyl 3-Phenoxypropionate 20 France, 776 (1957); 1H NMR (DCCl3) 6 1.31 [s, 6H, 
(CH3)2], 1.80-1.84 [m, 3H, H(3)], 4.16-4.20 [m, 2H, 
H(2)], 6.78-7.29 [m, 4H, Ar-H]; 13C NMR (DCCl3) 
ppm 30.5 [(H3C)2C], 31.1 [CH3] 37.7 [OCH2CH2], 63.0 
To demonstrate the methyl ester, as well as the ethyl 
ester, may be used to make members of composition 7, 
we illustrate the preparation of the corresponding 
methyl ester of composition 7 in which the Et group is 25 
replaced by Me and Xis 0. A solution of 3-phenoxypro-
pionic acid (10.0 g, 0.060 mol) and p-toluenesulfonic 
acid (0.6 g, 0.0033 mol) in methanol (250 mL) was 
[OCH2]; Ar-C [116.9, 120.4, 126.9, 131.6, 153.5]. 
4,4-Dimethylchroman-6-yl Methyl Ketone or 
1-(3,4-Dihydro-4,4-dimethyl-2H-l-benzopyran-6-yl)e-
thanone (5) (X=O) 
heated at reflux through 3 A molecular sieve for 36 Anhydrous A!Cl3 (3.4 g, 0.025 mol) was added in 
hours under N2 in a flask equipped with a Soxhlet ex- 30 small portions to a solution of 4,4-dimethylchroman 
tractor and a condenser. The solution was allowed to (compound 9; (X=O), 4.0 g, 0.024 mol) and acetyl 
cool to room temperature and then was concentrated to chloride (2.0 g, 0.025 mo!) in CH3NO2 (35 mL) under 
a volume of so mL, diluted with water (50 mL), and N2. After stirring at room temperature for 6 hours, 6N 
extracted with ether (2X75 mL). The combined or- HCl (35 Ml) was added slowly, and the resulting mix-
ganic layers were washed with 5% aqeuous NaHCOJ 35 ture was stirred for 10 minutes. The mixture was diluted 
with ether (40 mL), and the layers were separated. The 
(75 mL), H20 (75 mL), and brine (75 mL). After drying organic layer was washed with H2O (40 mL), saturated 
(Na2S04) the solution, the solvent was removed (vac- aqueous NaHCOJ (4 X 30 mL), HzO (40 mL), and brine 
uum). Vacuum distillation gave 9.45 grams (87.1%) of (2X40 mL). After drying (Na2so4) the solution, the 
the title ester as a colorless liquid: by 85° -87° C./0.1 mm 40 solvent was removed leaving a dark, reddish brown oil. 
(literature reports 85° C./0.4 mm; see C. E. Rehberg Vacuum distillation gave 3.4 grams (67.5%) of com-
and M. D. Dixon [J. Am. Chem. Soc. 72, 2205 [1972]): IR pounds (X=O) as a pale yellow liquid: bp 108°-112° 
(neat) 1740-1750 cm-1 (C=O); 1H NMR (DCCh) 6 C./0.01 mm; IR (neat) 1675-1685 cm-1 (C=O); 1H 
2.78 [s, 2H, CH2CO2CH3], 3.70 [s, 3H, OCH3], 4.23 [2H, NMR (DCC13) 6 1.36 [s, 6H, (CH3)2C), 1.83-1.87 [m, 
OCH], 6.84-7.02 and 7.18-7.35 [m, SH, ArH]; 13C NMR 45 2H, H(3)], 2.55 [s, 3H, H3CC=O], 4.24-4.28 [m, 2H, 
(DCCh) ppm 34.3 [H2CCO2], 51.7 [CH3], 63.2 H(2)], 6.83 [d, J =9 Hz, lH, H(8)], 7.71 [dd, J =9 Hz, 
[Ar-OCH2]; Ar-C [114.5, 120.8, 129.2, 158.3, 171.1]. J=3 Hz, 1H,H(71], 7.98 [d, J=3 Hz, H(S)]; 13C NMR 
2-Methyl-4-phenoxy-2-butanol (8) [X=O] 
A solution of methyl 3-phenoxypropionate (7.9 g, 50 
0.038 mo!) in dry ether (20 mL) was added dropwise 
under N2 to a stirred solution of CH3MgCl in THF 
(2.9M, 40.2 mL, 0.12 mol). The mixture was heated at 
reflux at 24 hours, allowed to cool to room temperature 
and quenched with saturated aqueous NR4Cl. The su- 55 
pematant liquid was decanted, and the residue was 
washed with dry ether (3 X 50 mL). The combined or-
ganic solutions were dried (Na2SO4), and the solvent 
was removed. Vacuum distillation gave 5.35 g (76.4%) 
60 
of compound 8 (X=O) as a colorless liquid: bp 81 • -84 • 
C./0.07 mm; IR (neat) 3140-3620 cm-1 (OH); 1H NMR 
(DCCh) 6 1.26 [s, 6H, (CH3)2], 1.95 [t, 2H, 
ArOCH2CH2], 2.8-3.0 [br s, lH, OH], 4.12 [t, 2H, 
ArOCH2], 6.82-6.96 (m, 3H, Ar-H], 7.16-7.3 [m, 2H, 65 
Ar-H]; 13C NMR (DCCl3) ppm 29.5 [CH3], 41.6 
[OCH2CH2], 64.9 [OCH2], 70.3 [(H3C)2C]; Ar-C 
[114.3, 120.8, 129.3, 158.3]. 
(DCC]J) ppm 26.3 [CH3], 30.6 [(H3C)2C], 37.0 
[OCH2CH2], 63.4 [OCH2], 116.9 [C(8)], 127.8, 128.16 
[C(S), C(7)], 130.0, 131.6 [C(4a), C(6)], 158.0 [C(8a)]; 
Mass spectral data for C13H16O2: m/e (M+) theoretical 
204.1150; Found: 204.1153. 
a,4,4-Trimethylchroman-6-methanol or 
3,4-Dihydro-a,4,4-trimethyl-2H-1-benzopyran-6-
methanol (12) (X=O) 
A solution of the ketone 5 (X=O) (3.0 g, 0.QlS mol) 
in anhydrous ether (15 mL) was added dropwise under 
N2 to a stirred suspension of LiAIH4 (0.8 g, 0.0211 mol) 
in dry ether (50 mL). The mixture was heated at reflux 
for 24 hours. After cooling to room temperature, ethyl 
acetate was added dropwise to destroy the excess 
LiAIH4. A solution of 5% HCl (SO mL) was then added, 
and the resulting mixture was stirred for 5 minutes. The 
layers were separated, and the aqueous layer was 
washed with ether (2XS0 mL). The combined organic 
layers were washed with 5% aqueous Na2CO3 (2 X 50 
mL) and brine (2XS0 mL). After drying (Na2SO4) the 
13 
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solution, the solvent was removed leaving a yellow oil 
which solidified after scratching. Recrystallization 
(hexane) gave 1.8 g (59.4%) of compound 12 (X=O) as 
a white solid: mp 70° -71 ° C.; IR (KBr) 3140-3640 
cm-I (OH);"IH NMR (DCCl3) 1.31 [s, 6H, (CH3)2C], 5 
1.43 [d, 3H, H3CHOH], 1.74-1.83 [m, 2H, H(3)], 
2.4-2.44 [s, lH, OH], 4.10-4.18 [m, 2H, H(2)], 4.76 [q, 
lH, CHOH], 6.76 [d, J=9 Hz, lH, H(8)], 7.07 [dd, J=9 
Hz, J =3 Hz, lH, H(7)], 7.28 [d, J =3 Hz, lH, H(5)]; 13C 
NMR (DCCl3) ppm 25.0 [H3CC=O], 30.6 [C(4)], 31.0 10 
[(H3C)2C], 37.6 [C(3)], 63.0 (C(2)], 70.2 [C(9)], 116.9 
[C(8)], 124.0, 124.3 [C(5), C(7)], 131.4, 137.7 [C(4)a, 
C(6)], 152.9 [C(8a)]; Mass spectral data for C13H1sO2: 
14 
[d, J =3 Hz, lH, H(5)], 8.06 [d, 2H, Ar-H]; Mass spec-
tral data for C23H26O3: m/e (M+) theoretical 350.1882; 
Found: 350.1884. The presence of the Z isomer in an oil 
obtained from the chromatography was indicated by 
the following IH NMR signals: 6 2.76-2.81 [m, H(3)], 
2.20 [s, 3H, Z CH=C(CH3)], 4.16-4.20 [m, H(2)], 6.44 
[br s, lH, Z CH=C(CH3)]. 
EXAMPLE IV 
To demonstrate the ease with which the correspond-
ing carboxylic acids might be obtained from the esters, 
the following synthesis of acid with X being O and R 
being H was performed. 
m/e (M+) theoretical 206.1307; Found: 206.1308. 
[1-(4,4-Dimethylchroman-6-yl)ethyl]triphenylphos-
phonium Bromide or 
[1-(3,4-Dihydro-4,4-dimethyl-2H-l-benzopyran-6-yl)e-




6-yl)-1-propenyl]benzoic Acid (X=O, R=H) 
The heteroarotinoid (X=O, R Et) (0.20 g, 0.57 
A solution of the alcohol compound 12 (X=O) (0.70 20 mmol) was heated at reflux under N2 for 4 hours in a 
g, 3.4 mmol) and triphenylphosphine hydrobromide (1.2 solution of NaOH (0.1 g, 2.50 mmol) in 95% C2HsOH 
g, 3.5 mmol) in methanol (30 mL) was stirred under N2 (2 mL) and H2O (5 mL). After cooling slowly to room 
at room temperature for 24 hours. The solvent was temperature, the solution was acidified (litmus) with 
removed (vacuum), and the resulting oil was triturated concentrated HCI. The resulting white solid was fil-
repeatedly with dry ether until it solidified. The white 25 tered, washed with water, and air-dried. Recrystalliza-
solid was stirred in dry ether (30 mL) at room tempera- tion (95% ethanol) gave 0.135 grams (73.4%) of acid 1 
ture under N2 for 4 hours, filtered, and dried (X=O, R H) as a white solid: mp 183°-183.5° C.; IR 
(110°C./ ~2 mm) to give 1.45 g (80.3%) of compound (KBr) 2390-3320 (OH, CH), 1670-1695 cm-1 (C=O); 
13 (X=O) as a white powder: mp 149°-155° C. (dee); 1H NMR (DCCl3) 6 1.38 [s, 6H, (CH3)2C], 1.84-1.9 [m, 
1H NMR (DCCl3) 6 1.08 [s, 3H, CH3], 1.14 [s, 3H, 30 2H, H(3)], 2.30 [s, 3H, CH=C(CH3)], 4.21-4.26 [m, 2H, 
CH3], 1.72-1.78 [m, 2H, H(3)], 1.83 [d, 3H, CHCH3], H(2)], 6.80 [s, lH, CH=C(CH3)], 6.83 [d, J =9 Hz, lH, 
4.12-4.18 [m, 2H, H(2)], 6.2-6.32 [m, lH, CHP+Ph3, H(8)], 7.29 [dd, J=9 Hz, J=3 Hz, lH, H(7)], 7.46 [d, 
Br-], 6.57 [d, lH, H(8)], 6.67 [d, lH, H(7)], 7.24 [br s J=3 Hz, lH, H(5)], 7.48 [d, 2H, Ar-H], 8.15 [d, 2H, 
lH, H(5)], 7.63-7.84 [m, 15H, P+(C6Hs)3]. The salt was Ar-H]; Mass spectral data for C21H22O3: m/e (M+) 
used without further purification. 35 theoretical 322.1569; Found: 322.1570. 
Ethyl EXAMPLE V 
(E)-p[2-(4,4-Dimethylchroman-6-yl)propenyl]benzoate Since a modification was required to produce com-
. or E!hyl pound 9 (X-N-CH3) from the general procedure, the 
(E)-4-[2-(3,4-Dihydro-4,4-dimethyl-2H-l-benzopyran- 40 following synthesis of the nitrogen analogue was per-
6-yl)-l-propenyl]benzoate (X=O) formed. 
A solution of n-butyllithium in hexane (1.55M, 2.13 
mL, 3.30 mmol) was added dropwise under N2 to a 
stirred suspension of the phosphonium salt 13 (X=O) 
Ethyl 3-phenylmethylaminopropionate (7) 
(X=N-CH3) 
(1. 75 g, 3 mmol) in dry ether (30 mL). The resulting 45 A solution of freshly distilled N-methylaniline (267.5 
dark, reddish brown mixture was stirred at room tern- g, 2.50 mol) and glacial acetic acid (50 mL) was placed 
perature for 5 minutes. A solution of the aldehyde 6 in a one liter, 3-necked flask equipped with a water 
(0.60 g, 3.37 mmol) in dry ether (15 mL) was then cooled condenser (carrying a CaC!i drying tube) and an 
added. The mixture changed from reddish brown to addition funnel charged with ethyl acrylate (250 g, 2.50 
creamy yellow, and a large amount of off-white solid 50 mol). The flask was warmed on a steam bath and the 
precipitated. After stirring at room temperature for 36 ethyl acrylate was added dropwise over a 25 minute 
hours, the mixture was filtered The resulting solid was period. The resulting yellow solution was heated with 
washed with ether (75 mL), and the combined filtrates occasional swirling for 17 hours during which time it 
were concentrated to give a yellow oil. The oil was turned deep red. This solution was washed with 5% 
chromatographed through a column (8X200 mm) 55 NaHCO3 (4X75 mL) and then with brine (3X75 mL). 
packed with neutral alumina (about 10 g). The product During the first wash, an emulsion formed, and 50 mL 
was eluted with 5% ether/hexane (250 mL). Concentra- of diethyl ether was added to destroy it. After drying 
tion of the eluent gave a viscous oil which was dis- (MgSO4) the solution, evaporation gave a red oil which 
solved in a minimum amount of boiling 95% ethanol. was distilled to give 404.5 grams, (78.2%) of compound 
Cooling the solution too• C. and scratching gave 0.30 60 7 (X-N-CH3) as a yellow oil: bp 105°-109° C./0.2 
grams (26.0%) of the compound (X=O) as a white mm (literature report 98°-100° C./0.05 mm; see D. W. 
granular solid: mp 72.5°-73.5° C.; IR (KBr) 1710-1725 Adamson, J. Chem. Soc. (Supplement I) S-144 (1949)): 
cm- 1 (C=O); 1H NMR (DCCh) 6 1.37 [s, 6H, IR (neat) 1740 (C=O) cm-1; IH NMR (DCCl3) 6 1.15 
(CH3)2C], 1.39 [t, 3H, OCH2CH3], 1.81-1.87 [m, 2H, [t, 3H, OCH2CH3], 2.46 [t, 2H, CH2CO2CH3, J =7.08 
H(3)], 2.27 [s, 3H, CH=C(CH3)], 4.17-4.24 [m, 2H, 65 Hz], 2.80 [s, 3H, NCH3], 3.59 [t, 2H, NCH2, 1=7.08 
H(2)], 4.38 [q, 2H, OCH2CH3], 6.77 [s, lH, Hz], 4.04 [q, 2H, OCH2CH3], 6.67 [m, 3H, o & 
CH=C(CH3)], 6.81 [d, J=9 Hz, lH, H(8)], 7.26 [dd, p-ArH], 7.18 [m, 2H, m-ArH]; 13C NMR (DCCb) 
1=9 Hz, J=3 Hz, lH, H(7)], 7.41 [d, 2H, Ar-H], 7.44 ppm 14.1 [OCH2CH3], 31.6 [C(2)], 37.9 [C(4)], 48.4 
4,826,984 
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[C(3)], 60.2 [OCH2], 112.3 [C(6, 10)], 116.5 [C(8)], 129.0 
[C(7,9)], 148.4 [C(5)], 171.7 [C(l)]; Mass spectral data 
for C12H11NO2: m/e (M+) 207.1259; Found: 207.1261. 
C6H6f'H3PO4, the yield of compound 9 (X=N-CH3) 
was 55%. 
EXAMPLE VI 
2-Methyl-4-(phenylmethylamino)-2-butanol (8) 5 An evaluation of the anticancer properties of the 
(X N-CH3) heteroarotinoids was made via the standard hamster 
A solution of methylmagnesium chloride (Aldrich, tracheal organ culture bioassay (see D. L. Newton, W. 
2.9M in THF, 414 mL, 1.20 mol) was placed in a one R. Henderson, and M. B. Sporn in Structure-Activity 
liter, 3-necked, round-bottom flask along with a mag- Relationships of Retinoids, National Cancer Institute, 
netic stirring bar. The flask was equipped with a ther- 10 Revised Edition, Feb. 26, 1980; and D. L. Newton, W. 
mometer, a dry ice condenser carrying a CaCli drying R. Henderson, and M. B. Sporn, Cancer Research, 40, 
tube, and an additional funnel charged with ethyl 3. 3413 [1980]). The assay involves the ability of a test 
phenylmethylaminopropionate (compound 7; compound in vitro to reverse keratinization in tracheal 
x N-CH3, 100 g, 0.483 mol). The apparatus was organ cultures obtained from vitamin A deficient ham-
flushed with nitrogen and the flask and contents were 15 sters. The relationship of vitamin A deficient epithelial 
cooled to _ 5• c. in an ice-salt bath. The ester 7 tissues and precancerous lesions is well known (see C. 
E. Orfanos, Retinoids-Advances in Basic Research and 
(X N-CH3) was added drop~ise at su~h a rate that Therapy, Springer-Verlag, New York, 1981). For exam-
the temperature stayed below 15 C. (45 mmutes). After 
1 
h dd" . f • 'd th 1 t' . h 1 • p e, t e a 1t1on o retm01 s can reverse e anap as 1c w_arm~nf slowlyd~~ ~oo; ;~mp~ra:ureri e so_ uttton was 20 epithelial lesions induced in prostate glands by chemical 
st1rre or an a ttlon mmu e~. e ~ ur~ was carcinogens (see D. P. Chopra and L. J. Wilkoff, Proc. 
~oured onto 400 grams of crushed ice contamed ma 2 Am Assoc. Cancer Research, 16, 35 (1975); and I. Las-
hter Erlenmeyer flask, an~ the1_18_5 mL '?f ~oncentrated nitzki, British Journal of Cancer, 9, 434 [1955]). The 
J:!Cl was slowly added with stirnng. Stimng w~s con- basic procedure for the bioassay involving the vitamin 
tmued f~r _ 1 hour and th~n water was added to dissolve 25 A deficient hamster tracheal organ culture is presented 
the prec1p1tated salts which brought the total volume to below with the results obtained for some of the compo-
1400 mL. The solution was then neutralized by addition 
of solid K2CO3 (50 g). Two layers separated and the 
aqeuous layer was extracted with HCCl3 (3 X 100 mL). 
The combined organic portions were washed with brine 30 
(50 mL) and dried (K2CO3). Evaporation of the solvent 
gave an orange oil which was distilled under vacuum to 
give 74.7 g (80.1%) of compound 8 (X=N-CH3) as a 
pale yellow liquid: bp 95° -99° C./0.08 mm; IR (neat) 
cm-13150-3650 cm-I (OH); IH NMR (DCCb) 6 1.62 35 
[s, 6H, HOC(CH3)2], 2.06 [t, 2H, J=7.82 Hz, 
NCH2CH2], 3.24 [s, 3H, NCH], 3.34 [s, lH, OH], 3.81 [t, 
2H, J =7.86 Hz, NCH2], 7.15 [m, 3H, o & p-ArH], 7.64 
[t, 2H, m-ArH]; 13C NMR (DCCl3) ppm 29.3 
[C(l,12)], 38.1 [C(ll)], 38.5 (C(3)], 48.5 [C(4)], 69.8 40 
[C(2)], 112.8 [C(6,10)], 116.4 [C(8)], 128.9 [(C(7,9)], 
149.1 [C(5)]; Mass spectral data for C12H19NO: m/e 
(M+) 193.1467; Found: 193.1464. 
sitions. 
The harvested tracheas were cultured in a serum-free 
medium and were gassed with 50% 02, 45% N2, and 
5% CO2. The serum-free culture consists of CMRL 
Medium 1066 with crystalline bovine insulin (1.0 
µg/mL), hydrocortisone hemisuccinate (0.1 µg/mL), 
glutamine (2 mM), pencillin (100 inits/mL), and strepto-
mycin (100 µg/mL). The cultures were incubated for 3 
days at 35° -36° C. After incubation in the retinoid-free 
medium, some of the tracheas were harvested. Most of 
the specimens had significant squamous metaplasia. The 
remaining cultures were divided into 3 groups. The first 
group was treated with the experimental heteroaroti-
noid in spectrograde dimethyl sulfoxide (DMSO) at 
concentrations of 1Q-8M, lQ-9M, and l0- 10M (final 
concentration of DMSO in culture medium was 0.1 % ). 
The other groups were culture media without test 
heteroretinoid and culture media with the standard all l,4,4-Trimethyl-1,2,3,4-tetrahydroquinoline 
(9)(X=N-CH3) 45 trans-retinoic acid in DMSO at concentrations of 
10-10M, 10-IIM, and to- 12M (all trans-retinoic acid 
has an EDso of 1 X 10-1 IM). The all trans-retinoic acid 
was used with each culture because it is the most potent 
A solution ofcompound 8 (X = N-CH3, 21.3 g, 0.110 
mol) in CH2Cli (350 mL) was placed in a 500 mL, 
round-bottom flask equipped with a magnetic stirring 
bar. To this was added cautiously a solution of 50 
F3CCO2H (5 mL) in concentrated H2SO4(50 mL). The 
mixture was boiled for 3 hours after which time the 
CH2Cli was evaporated. The residue was neutralized 
by the addition of a saturated aqueous solution of 
K2CO3. The resulting slurry was extracted with HCCb 55 
(3X75 mL), and the combined extracts were washed 
with 5% NaHCO3 (3 X 50 mL) and then with brine 
(2X50 mL). After drying (K2CO3), the solution gave a 
red oil which was distilled under vacuum to yield com-
pound 9 (X=N-CH3, 14.8 g, 77.1%) as a colorless oil: 60 
bp 137°-139° C./0.06 mm; 1H NMR (DCCb) 61.24 [s, 
6H, C(CH3)2], 1.69 [t, 2H, NCH2CH2, J =5.96 Hz], 2.79 
[s, 3H, HCH3], 3.11 [t, 2H, NCH2, J = 5.94 Hz], 
6.51-7.14 [m, 4H, ArH]; 13C NMR (DCCb) ppm 31.0 
[C(l0,11)], 31.9 [C(4), 37.3 [C(3)], 39.2 [C(9)], 47.6 65 
[C(2)], 131.2 [C(4a)], 145.3 [C(8a)]; Mass spectral data 
for C12H11N: m/e (M+(175.1361; Found: 175.1358. 
When the cyclization was attempted using P2Os in 
of natural occuring retinoids in reversing keratinization 
caused by vitamin A deficiency and is a good com-
pound to determine if the assay is working correctly. A 
final culture was prepared with only DMSO present. 
The culture medium was changed three times per 
week for 10 days. At the end of that time, all tracheas 
were harvested and fixed in a 4% ( or sometimes 10%) 
formaldehyde-1 % glutaraldehyde solution. The mate-
rial was then embedded in paraffm and cross-sections of 
the tracheas were examined under a microscope for the 
presence of keratin or keratohyaline granules. A syn-
thetic retinoid was judged as having good anticancer 
activity if neither keratin nor keratohyaline granules 
were present or if only keratohyaline granules were not 
present. If both were seen, the retinoid was considered 
inactive. The following Table contains the resulting test 
data which clearly demonstrates the activity of several 
of the compositions according to the present invention. 
The E compound (X=S, R=C2Hs) showed very good 
activity and approximately one-half log unit less than 
4,826,984 
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tion, the solvent was removed, and the solid residue was 
vacuum distilled to remove a lower boiling liquid (bp 
42% 0.15 mm-95° C./0.07 mm, mostly 4-bromoanisole). 
A solution of the remaining solid residue in H2CCh was 
treated with decolorizing charcoal. Evaporation of the 
H2CCh gave a tan solid which was recrystallized 
(twice, heptane) and dried [traces of solvent were re-
moved (high vacuum)] to give the aryl ether as a white 
the all trans-retinoic acid. Heteroartinoid E compound 
(X=O, R=C2H5) and the acid E compound (X=O, 
R=H) demonstrated good activity only one log unit 
less than the standard all trans-retinoic acid. The sulfox-
ide analogue (E compound wherein, X=S--.0, 5 
R=C2H5) was less active but nevertheless displayed 
activity within the range of the standard. Since the 
compositions described within this_ application have 
heteroatoms which increase water solubility (and less 
lipid solubility), they appear to be less toxic than all 
trans-retinoic acid which is known to be acutely toxic in 
single large doses (see C. E. Orfanos, Retinoids-
Advances in Basic Research and Therapy, Springer-Ver-
lag, New York, 1981; and T. Moore, Vitamin A, El-
sevier Publishing Company, New York, 1957). Slough- 15 
ing of the cells in the culture studies was common with 
the toxic all trans-retinotic acid but was not observed 
with the heteroarotinoids in this work. 
10 crystalline solid (37. 7 g, 61.5% ); mp 87.8° -89.1 • C. [lit-
erature reports 82°-84° C.; see P. Gates, D. Baldwin, C. 
A. Wilson and J. Gillion (Fison's Ltd.), U.S. Pat. No. 
4,333,759; Chem Abstr. 1982, 97, 215978 p]. Another 3.4 
g (5.5%) could be obtained by the following procedure. 
Evaporation of the mother liquors gave a solid which 
TABLE I 
Activity of Compounds in the Hamster 
Tracheal Organ Culture Assay 
Aroretinoid Concentration(M) % Active 
trans-retinoic acid 10-10 76.9 
10-ll 41.7 
10-12 23.1 








10- 10 50.0 
10-11 28.2 






trans-retinoic acid 10-I0 83.7 
11-11 50.0 
10-12 33.3 
(X = 0, R = H) 10-8 100 
10-9 100 
10- 10 57.1 
10-ll 11.14 
EDso(M)0 
2 X 10-tl 
6 X 10-ll 
9 X 10-12 
I X 10- 10 
IX 10-ll 
6 X 10- 10 
I X 10-l0 
was dissolved in H2CCh. Partial decolorization (char-
coal) of the H2CCh solution followed by evaporation 
gave a solid residue which was recrystallized (twice; 
20 
heptane); the yield of ether was 41.1 g (67%). IR(KBr) 
1246 cm-I (C-O; IH NMR (DCCl3) 61.43 [s, 6H, 
C(CH3), 3.96 (s, 2H, OCH2), 6.78 (d, lH, Ar-H), 
7.32-7.41 (m, 2H, Ar-H); 13C NMR (DCCb) ppm 25.8 
25 [C(CH3)2], 40.4 [C(CH3)2], 53.3 [CH2C], 55.3 [OCH3]; 
Ar-C [113.1, 130.6, 131.2, 135.4, 157.2] Both hydrogen 
and carbon-13 NMR spectral shifts were measured from 
tetramethylsilane (TMS on a Varian XL-300 NMR 
30 spectrometer confirming the correct hydrogen distribu-




2 X 10- 10 
EXAMPLE VIII 
5-Bromo-2.3-dihydro-3.3-dimethylbenzofuran (21) 
A mixture of 2-(2-methoxy-5-bromophenyl)-2-meth-
"ED5o(M) is the dOIC for reversal orkeratinization in epithelium or 50% or retinoid- yl-1-chloropropane (ether above; 12.60 g 0.045 mo!), 
deficient hamster tracheas in organ culture. 45 d · 
pyridine hydrochloride (23. 7 g 0.205 mol), an qumo-
line (22.9 g 0.177 mol) was heated to 164° C. (boiling 
EXAMPLE VII isobutylbenzene bath) under N2 with stirring over a 
2-(2-Methoxy-5-bromophenyl)-2-methyl-1-chloropro- period of 0.6 hours. After stirring a reflux (164°-167° 
pane (20) 50 C.) for 3 hours, the mixture was partitioned between 
Concentrated H2SO4 (4 mL, 7.6 g, 0.077 mol) was ice-cold 6N HCl (225 mL). The organic layer was sepa-
added dropwise under N2 to stirred 4-bromoanisole rated and the aqueous layer was extracted (ether 200 
(44.0 g, 0.235 mol). After warming the mixture to 36° C. mL). After drying (MgSO4, overnight) the combined 
(warm water bath), distilled B-methallyl chloride (21.5 organics, the solvent was evaporated and the residual 
mL, 20.0 g, 0.221 mol) was added dropwise to the 55 oil was vacuum distilled to give the cyclic ether (8.5 g, 
stirred mixture in 4 equal portions over a period of 1.6 
hours ( 4 X 0.4 h). During the addition of the B-methallyl 82%) as a colorless liquid: bp 48.2" -60.0" C./0.05-0.06 
chloride, the temperature of the mixture was maintained mm [literature reports 62°-64° C./0.01 mm; see P Gates, 
at 35°-44° C. (using a warm water bath). After the addi- D. Baldwin, C. A. Wilson, and J. Gillon (Fison'Ltd.), 
tion of the B-methally chloride was complete (1.6 h), 60 U.S. Pat. No. 4,333,759; Chem. Abstr. 1982, 97, 215978 
the reaction mixture became solid and was allowed to p)]. TLC analysis [1:5 ethyl acetate:petroleum ether (bp 
stand [1 hour over water bath (29°-32° C.), 2 hours at 50° -110" C.)] indicated traces of two impurties. IR(neat) 
room temperature]. The wet solid was partitioned be- 1197 cm-I (C-O); IH NMR (DCC13) 61.31 [2, 6H, 
twe~n H2CCh (500 mL) and H2O) (175 mL). ~e or- C(CH)] 4_24 (s 2H OCH) 6.67 (D 1H Ar-H) gan1c layer was separated and then washed with 5% 65 2 ' ' ' . 
13 
2 ' ' ' ' 
aqueous NaHCQ3 (175 mL) and H2o [175 mL, 5 mL of 7.18-7.25 (m, 2H, Ar-H), C NMR (DCCb) ppm 27.3 
brine being added to destroy an emulsion which [C[CH3)2] 84.7 [OCH2]; Ar-C [111.2, 112.2, 125.4, 




CCr"' C(Y'OH 5 
0 0 
EXAMPLE IX EXAMPLEX 
1-(2.3-Diydro-3.3-dimethyl-5-benzofuranyl)ethanol (22) lO [1-(2,3-Dihydro-3,3-dimethyl-5-benzofuranyl)ethyl]tri-
phenylphosphonium Bromide (23) 
A mixture of the precursor ether (0.21 g. 0.9 mmol), 
Mg turnings (1.0 g 0.041 g at) and dry THF (2 mL) was 
heated (heat gun) under N2 until the mixture turned 
cloudy (ca 15 min). Dry THF (15 mL) was added to the 15 
mixture which was then heated to reflux. A solution of 
ether 21 (2.92 g, 12.9 mmol) in dry THF (25 mL) was 
added dropwise to the vigorously stirred mixture over a 
period of 0.75 hours. After vigorous stirring at reflux 20 
for 2.75 hours, another 0.25 g (0.010 g at) of Mg turn-
ings were added. The new mixture was stirred at reflux 
for 0.75 hour and with no external heat for 0.5 hours. 
Upon cooling the mixture to - 5° to - 10° C. (ice-salt 
bath), a solution of freshly distilled acetaldehyde (2.0 g, 25 
0.045 mol) in dry THF (20 mL) was added dropwise to 
the vigorously stirred mixture over a period of 0. 7 
hours. This reaction mixture was stirred in an ice-salt 
bath ( - 5° to -10° C.) for 1.5 hours, after which time a 
30 
solution of acetaldehyde (0.9 g, 0.020 mol) in dry THF 
(5 mL) was added dropwise (over a period of about 0.2 
h) and the new mixture was stirred 0.3 hours. With 
continued cooling (-5° to -10° C.), saturated aqueous 
NH4Cl ·(3 mL) was added and the excess Mg turnings 35 
were removed by filtration. Saturated aqueous Nff4Cl 
(10 mL) and ether rinses (of glassware and Mg turnings, 
60 mL) were added to the filtrate. After separating the 
organic layer, the aqueous phase (pH>8) was acidified 
(pH 6.5 to 7) with saturated aqueous NH4Cl (15 mL) 40 
and 4% H2SO4 (14 mL). The aqueous solution was 
extracted with ether (5 X 40 mL) and ether (90 mL) was 
added to the combined organics. The organic solution 
was washed with saturated aqueous NaHCO3 (75 mL) 45 
and brine (50 mL). After drying (MgSO4) the solution, 
the solvent was removed, and the residual oil was chro-
matographed through a circular silica gel plate (4 mm) 
spun by a Chromatotron (Model 7924T, Harrison Re-
search, 840 Moana Court, Palo Alto, Calif. Half of the so 
product was eluted with ether/petroleum ether (bp 
50°-110° C.) 20:1, 8:1, then 4:1 and then the same sol-
vent system was used to elute the other half. In both 
separations, the 4:1 ratio was required to elute the title 
compound. Concentration of the eluent in the desired 55 
fractions gave 1.18 g (44%) of the alcohol as a light 
yellow, viscous oil. TLC analysis (1:4 ether:petroleum 
ether, bp 50°-110° C.) indicated the compound was 
essentially pure. 
60 IR (neat) 3150-3650 cm-I; IH NMR (DCCh) 61.31 
[s, 3H, C(CH3)CH3], 1.32 [s, 3H, C(CH3)CH3], 1.45 [d, 
3H, CH(CH3)], 2.36 (bs, lH, O-H), 4.81 [q, lH, 
CH(CH3)], 6.71 [d, J=8 Hz, lH, H(7)], 7.08 [dd, J=8 
Hz, J=l.9 Hz, lH, H(6)], 7.13 [d, J=l.9 Hz, lH, H[4)]; 65 
13C NMR (DCCl3) ppm 25.1 [CH(CH3)], 27.5 
[C(CH3)z], 41.9 [C(CH3)z, 7.02 [C-OH], 84.7 [OCH2]; 
Ar-C [109.3, 119.5, 125.4, 136.8, 138.3, 158.6]. 
A solution of the precursor alcohol 22 (0.28 g, 1.46 
mmol) in methanol (5 mL) was added dropwise (about 
3 min.) under N2 to a stirred mixture of triphenylphos-
phine hydrobromide (0.50 g, 1.46 mmol) in methanol 
(10 mL). After 7 min, the mixture became a solution 
which was stirred at room temperature for 40 hours. 
Evaporation of the solvent resulted in foaming and gave 
a colorless solid. The solid was changed to a powder by 
stirring the suspension of crude 23 in ether for 4.5 hours. 
After filtering the solid, the fine powder was partially 
dried (air) and finally dried by high vacuum (P2Os, 100° 
C.), to give 0.69 g (88%) of the phosphonium salt as a 
creamy white powder; mp 207°-212° C.; 1H NMR 
(DCCl3) 61.14 [s, 3H, (CH3)CCH3], 1.19 [S, 3H, 
(CH3)CCH3], 1.82 (dd, 3H, CHCH3), 4.22 (s, 2H, 
OCH2), 6.56 (m, lH, CHCH3), 6.61 (d, lH, Ar-H), 
6.85-6.98 (m, 2H, Ar-H), 7.64-7.92 [m, 15H, 








propenyl]benzoate or Methyl 
(E)-4-(2-(2,3-Dihydro-3,3-dimethyl-5-benzofurany 1)-1-
propenyl]benzoate (24) 
A solution of-n-butyllithium (1.38M, 2.0 mL, 2.76 
mmol) in hexane was added dropwise (about 3 minutes) 
under N2 to a stirred suspension of the precursor phos-
phonium salt 23 (1.45 g, 2.72 mmol) in dry ether (20 
mL). The resulting red mixture was stirred at room 
temperature (0.2 hours). After cooling the mixture in a 
dry ice-acetone bath (78° C, 0.2 hours) a solution of 
aldehyde 33 (0.45 g, 2.74 mmol) in dry ether (20 mL) 
was added dropwise over a period of 1 minute. The 
mixture became cream-colored and a large amount of 
creamy-white solid precipitated. After stirring at room 
temperature 54 hours, ether (75 mL) was added to the 
mixture. The mixture was filtered and the solid was 
washed with ether (140 mL). The filtrates were com-
bined and the solvent was evaporated leaving a yellow 
oil which was chromatographed through a circular 
silica gel plate (4 mm) spun by a Chromatotron (Model 
7924T, Harrison Research, 840 Moana Court, Palo 
Alto, Calif). The product was eluted with 1 :9 ethyl 
acetate:hexanes (200 mL). Fraction 2 and 3 were set 
aside; fractions 4-10 were combined and evaporated to 
about 2 mL. This solution was chromatographed as 
4,826,984 
21 
described above and fractions 2' and 3' were combined 
with 2 and 3. Evaporation of the solvent gave an oil 
which solidified. Recrystallization (minimum amount of 
hot 95% ethanol) gave, after drying (P2Os, high vac-
uum, 61 • C:), 1.88 mg (21.4%) of E-ester 24 as colorless 5 
flakes: mp 100.3°-100.8° C.; IR (KBr) 1717 cm-1 
(C==O); 1H NMR (DCCb) 1.38 [s, 6H, C(CH3)2], 2.29 
[d, J = 1.2 Hz, 3H, CH=C(CH3)], 3.93 (s, 3H, OCH3), 
4.28 (s, 2H, OCH2), 6.77 [bs, lH, CH=C(CH3)], 6.80 [d, 
J=8.3 Hz, lH, H(7)], 7.28 [d, J=2 Hz, lH, H(4)], 7.31 10 
[dd, J =8.3 Hz, J =2 Hz, lH, H(6)], 7.41 (d, 2H, Ar-H), 
8.03 (d, 2H, Ar--H); 13C NMR (DCCL3) ppm 17.9 
[CH=C(CH3)], 27.6 [(CH3)2C], 41.9 [(CH3)2C], 52.0 
[OCH3], 84.9 [OCH2]; Ar-C [109.3, 120.0, 125.1, 126.1, 
127.6, 129.0, 129.4, 136.4, 136.8, 139.6, 143.4, 159.0], 167 15 
[C==O]; Anal. Calcd for C21H22O3: C, 78.23; H, 6.88. 
Found D, 77.88; H, 6.98. Evaporation of the solvent 
from the mother liquors and recrystallization (hot 95% 
22 
6.78-6.83 [m, 2H, CH=C(CH3) and H(7)], 7.29 [d, J =2 
Hz, lH, H(4)], 7.32 [dd, J =8.2 Hz, J =2 Hz, lH, H(6)], 
7.46 (d, 2H, Ar-H), 8.12 (d, 2H, Ar-H) 13C NMR 
(DCCb) ppm 18.0 [CH=C(CH3)], 27.6 [(CH3)2C], 41.9 
[(CH3)2C], 84.9 [OCH2]; AR-C (109.4, 120.0, 125.1, 
126.1, 126.7, 129.1, 130.1, 136.4, 136.8, 140.0, 144.3, 
159.1], 171.7 (C==O). Anal. Calcd. for C20H20O3; C, 
77.90; H, 6.54. Found: C, 77.20; H, 6.48. 
(26) 
0 
EXAMPLE XIII ethanol) of the residue gave needles and diamond-
shaped crystals. Manual separation of the crystals and 20 
recrystallization (hot 95% ethanol) of each gave an- 4,4-Dimethylchroman or 
other 23 mg (2.6%) ofE-ester 24 as colorless, diamond- 3,4-dihydro-4,4-dimethyl-2-H-l-benzopyran (27) 
shaped crystals and needles of Z-ester 25 <18 mg, 2%) A solution of 2-methyl-4-phenoxy 2-butanol (6.1 g, 
were also obtained: mp 103.o•-104-2° C.; 1H NMR 33.62 mmol) in nitromethane (40 mL) was added drop-
(DCCl3) 61.21 [s, 6H, C(CH3)2], 2.22 [d, J = 1.3 Hz, 3H, 5 . d N · d · f h d CH=C(CH3)], 3.87 (s, 3H, OCH3), 4.24 (s, 2H, OCH2), 2 wise un er 2 to a st1rre . sus?ens1on o an y rous 
6.43 [bs, lH, CH=C(CH3)], 6.71 [d, J =8.2 Hz, lH, AlCl3 (?.1. g, 45.35 mmol) m mtromethane ~~4 mL). 
H(7)], 6.84 [d, J = 1. 7 Hz, lH, H(4)], 6.96 [dd, J = 8.2 Hz, After st1rnng at room temperature for an add1t1onal 24 
J = 1.7 Hz, lH, H(6)], 7.02 (d, 2H, Ar-H), 7.77 (d, 2H, hours, a solution of 6M HCI (65 mL) was added slowly. 
Ar-H); 13C NMR (DCCI3) ppm 27.1 [CH=C(CH3)], The resulting mixture was stirred for 10 minutes and 
27.4 [(CH3)2C], 41.8 [(CH3)2C), 51.9 [OCH3], 84.7 30 diluted with ether (50 mL). The layers were separated, 
[OCH2]; Ar-C (109.6, 122.6, 125.1, 127.3, 127.7, 128.8, and the organic layer was washed with H2O (50 mL), 
129.1, 133.6, 136.8, 141.6, 142.9, 158.6] 167.0 [C==O]. saturated NaHCO3(4X50 mL), H2O (50 mL), and satu-
rated solution of NaCl (2 X 50 ml). After the solution 
(24) 
35 
was dried (MgSO4, 30 minutes), the solvent was re-
moved (vacuum). Vacuum distillation of resulting dark 
brown oil gave 3.45 g (62.8%) of the pyran 27 as a 
colorless liquid: bp 38°-42° C./0.05 mm [literature re-






propenyl]benzoic acid or 
(E)-4-(2-(2,3-Dihydro-3,3-dimethyl-5-benzofuranyl)-1-
propenyl]benzoic acid (26) 
40 
Marey Bull. Soc. Chim. France, 776 (1957)]; IH NMR 
(DCCl3) 61.27 [s, 6H, (CH3)C], 1.83 [m, 2H, CH2], 
6.88-7.24 [m, 4H, Ar-H]; 13C NMR (DCCl3) ppm 30.5 
[C(CH3)2], 31.1 [CH3)2C], 37.7 [CH2], 63.0 [OCH2], 








The E-isomer of heteroarotinoid 24 (R=CHJ) (90 Anhydrous AlCb (2.99 g, 22.51 mmol) was added in 
mg, 0.28 mmol) was heated at reflux under N2 for 5 small portions to 4,4-di':11ethylchroman (3.45 g, 21.~0 
hours in a solution ofNaOH (0.06 g, 1.5 mmol) in 95% 60 mmol) and acetyl chlonde (1.51 mL, 21.30 mmol) m 
C2HsOH (1.2 mL) and H2o (3 mL). After cooling CH3NO2 (30 mL) under N2. After stirring at room tern-
slowly to a few degrees above room temperature, the perature for 6 hours, 6M HCI (30 mL) was added 
solution was acidified (litmus) with 6N HCI. A white slowly, and the resulting mixture was stirred for 10 
solid formed and was filtered, washed (H2O, about 5 minutes. The mixture was diluted with ether (70 mL) 
ml) and recrystallized (hot 95% ethanol) to give 38 mg 65 and the layers were separated. The organic layer 
(44%) of E-acid 26 as white crystals: mp 197.3°-198.5° washed with H2O (50 mL), saturated aqueous NaHCO3 
C.; 1H NMR (DCCh) 61.39 [s, 6H, (CH3)2C], 2.30 [d, (4X40 mL), H2O (50 mL), and saturated solution of 
J = 1 Hz, 3H, CH=C(CH3)], 4.28 (s, 2H, OCH2), NaCl (50 mL). After the solution was dried (MgSO4, 30 
4,826,984 
24 23 
minutes) the solvent was removed to leave a dark, red-
dish brown oil. Vacuum distillation gave 3.09 g 
(89.03%) of the ketone 28 as a pale yellow liquid: bp 
94• -95° C./0.1 mm [literature reports 108° -112° C./0.01 
mm; see K. M. Waugh, K. D. Berlin, W. T. Ford, E. M. 
Holt, J.P. Carrol, P.R. schomber, M. D. Thompson, 
and L. J. Schiff J. Med. Chem., 28, 116 (1985)]; IR (neat) 
1675-1685 cm-I (C=O); 1H NMR (DCCl3 61.38 [s, 
6H, (CH3)2C], 1.84 [m, 2H, CH2], 2.52 [s, 3H, CH3C], 
4.26 [m 2H, CH2O], 6.82 [d, lH, H(8)], 7.71 [dd, lH, 
H(7)], 7.99 [d, lH, H(5)]; 13C NMR (DCCh) ppm 26.1 
[CH3], 30.5 [C(CH3)2], 30.6 [CCH3)2C], 37.0 [CH2], 63.3 
[CH2O], 116.7 [Cs], 127.5 [Cs], 127.9 [C1], 130.0, 131.6 
[C(4a), C6], 157.8 [C(8a)], 196.4 [C=O]. 
mmol) in methanol (30 mL) was stirred under N2 at 
room temperature for 24 hours. The solvent was re-
moved (vacuum), and the resulting oil was triturated 
repeatedly with dry ether until it solidified. The white 
5 solid was suspended and stirred in dry ether (30 mL) at 
room temperature under N2 for 4 hours, filtered, and 
dried (110° C./62 mm) to give 1. 75 g (96.9%) of the salt 
as a white powder: mp 152°-156° C. (dee) [literature 
reports 149°-155° C.; see K. M. Waugh, K. D. Berlin, 
10 W. T. Ford, E. M. Holt, J.P. Carrol, P.R. Schomber, 
M. D. Thompson, and L. J. Schiff J. Med. Chem, 28, 116 
(1985)]; IH NMR (DCCl3) 61.08 [s, 3H, CH3], 1.14 [s, 
3H, CH3], 1.76 [m, 2H, H(3)], 1.83 [d, 3H, CHCH3], 4.16 
[m, 2H, H(2)], 6.3 [m, lH, CHP+Ph3•Br-J, 6.57 [d, lH, 
15 H(8)], 6.67 [d, lH, H(7)], 7.74 [brs, lH, H(5)], 7.63-7.84 












6-yl)- l-propenyl]benzoate (31) and the Z-Isomer (32) 
A solution of the methyl ketone 28 (2.12 g, 10.38 
mmol) in anhydrous ether (10 mL) was added dropwise 
under N2 to a stirred suspension of LiAIH4 (0.59 g, 15.57 30 mmol) in dry ether (38 mL). The mixture was heated at 
reflux for 24 hours. After cooling to room temperature, A solution of n-butyllithium in hexane (1.39M, 16.35 
ethyl acetate was added dropwise to destroy the excess mL, 22.56 mmol) was added dropwise under N2 to a 
LiAJH4. A solution of 5% HCI (30 mL) was then added, stirred suspension of the precursor phosphonium salt 
and the resulting mixture was stirred for 5 minutes. The 
35 
(8.0 g, 15.04 mmol) in dry ether (145 mL). The resulting 
layers were separated, and the aqueous layer was dark reddish brown mixture was cooled to 78° C., and a 
washed(ether2X50mL). The combined organic layers solution of methyl 4-formylbenzoate (2.47 g, 15.04 
were washed with 5% aqueous Na2CO3 (2 X 50 mL) and mmol) was added over a period of 3 minutes. The solu-
water (50 mL). After the solution was dried (MgSO4, 30 tion was stirred for a few minutes at - 78° C. and then 
minutes) the solvent was removed leaving a yellow oil at room temperature for 48 hours. The mixture changed 
which solidified after scratching. Recrystallization 40 from reddish-brown to an off white color. After 48 
(hexane) gave 1.48 g 70.0% of the alcohol as a white hours, the reaction mixture was filtered. The resulting 
solid: mp 71 • -72° C. [literature reports 70° -71 • C.; see solid was washed with 350 mL of ether (anhydrous); the 
K. M. Waugh, K. D. Berlin, W. T. Ford, E. M. Holt, J. filtrate was concentrated to a yellow oil. This yellow oil 
P. Carrol, P. R. Schomber, M. D. Thompson, and L. J. was refrigerated for 8 hours and became a yellow solid. 
Schiff J. Med. Chem 28, 116 (1985)]; IR (KBr) 45 This yellow solid was passed through 30 g of silica gel 
3140-3640 CM- 1 (OH); 1H NMR (DCCl3) 61.32 [s, 6H, (column, 8X200 mm). The product was eluted with 500 
(CH3)2C], 1.50 [d, 3H, CH3], 1.31 [s, lH, OH], 4-20 [m, mL of hexane: ethyl acetate (4:1). Concentration of the 
2H, H(2)], 4.84 [q, lH, CHOH], 6-76 [d, lH, H(S)], 7.o7 eluent gave a viscous oil from which solid was obtained 
[dd, lH, H(7)], 7.28 [d, lH, H(5)]; 13C NMR (DCCl3) at room temperature. The white solid was dissolved in 
ppm 24.9 [CH3], 3.06 [C(4)], 31.0 [(CH3C)2C], 37.6 5o · · fb ·1· 95nt h I d fi1 d 
[C(3)], 62.9 [C(2)], 70.2 [C(9)], 116.S [C(S)], 123_9, 124.2 a mm1mum amount o 01 mg ,o et ano an . 1 tere_ 
[C(5) C(7)] 131.1 137_6 [C(4a) q 6)] 152_9 [C(Sa)]. hot. ~fter the filtrate was concentrated, cool~ng this 
' ' ' ' ' solution to room temperature gave 1.82 g ofwh1te crys-
tals (35% ): mp 90° -90.5° C.; IR (KBr) 1710-1725 cm - 1 
<29> 55 (C=O); IH NMR (DCCIJ) 1.4 [s, 6H, H(9), H(lO)], 1.9 
[m, 2H, H(3)], 2.3 [s, 3H, H(12)], 3.9 [s, 3H, H(21)], 4.2 
[m, 2H, H(2)], 6.8 [ps, IH, H(13)], 6.84 [d, IH, H(8)], 7.3 
[dd, IH, H(7)], 7.4 [d, IH, H(5)], 7.5 [d, 2H, H(l5), 
H(19)], 8.6 [d, 2H, H(16) H(18)]; 13C NMR (DCCIJ) 
EXAMPLE XVI 
[1-4,4-Dimethylchroman-6-yl)ethyl]triphenylphos-
phonium Bromide or 
[ 1-(3,4-Dihydro-4,4-dimethyl-2H-l-benzopyran-6-yl)e-
thyl]triphenylphosphonium Bromide (30) 
A solution of the alcohol precursor 29 (0.70 g, 3.4 
mmol) and triphenylphosphine hydrobromide (1.2 g, 3.5 
60 ppm 17.8 [C(l2)], 30.7 [C(4)], 31.1 [C(9), C(I0)], 37.6 
[C(3)], 52.1 [C(21)], 63.1 [C(2)], 116.8 [C(8)], 124.5 
[C(5)], 124.9 [C(7)], 125.9 [C(13)], 129.0 [C(l5), C(l9)], 
129.5 [C(16), C(18)], 167.0 [C(20)], non-protonated and 
vinylic carbons (127.6, 131.3, 135.7, 139.5, 143.4, 153.4); 
65 mass spectral data for C22H24O3: m/e (M+) 336.1725; 
found 336.1728. The mother liquor from the crystalliza-
tion of the E-isomer 31 contained predominantly the 
Z-isomer 32 (105 mg, 2.0%) as a white needles: mp 
4,826,984 
25 26 
80°-80.5° C.; 1H NMR (DCCh) 61.12 [s, 6H, H(9), EXAMPLE XIX 
H(lO)], 1.78 [m, 2H, H(3)], 2.20 [s, 3H, H(12)], 3.86 [s, 
3H, H(21)], 4.17 [m, 2H, H(2)], 6.43 [s, lH, H(13)], 6.73 (E)-4-[2-Methyl-2-(4,4 
[d, lH, H(8)], 6.95 [dd, lH, H(7)], 7.03 [d, lH, H(5)], dimethylchroman-6-yl]benxonitrile (34) 
7.51 [d, 2H, H(15), H(19)], 7.78 [d, 2H, H(16), H(l8)]; 5 A solution of n-butyllithium in hexane (1.55M, 9.40 
13C NMR (DCCl3) ppm 26.79 [C(12)], 30.42 [C(4)], mmol, 6.15 mL) was added dropwise under N2 to a 
30.78 [C(9), C(lO)], 37.48 [C(3)], 51.91 [C(21)], 63.08 stirred suspension of the precursor phosphonium salt 30 
[C(2)], 116.9 [C(8)], 125.0 [C(5)], 126.5 [C(7)], 126.5 (5.00 g, 9.40 mmol) in dry ether (100 mL). The resulting 
[C(13)], 129.1 [C(15)], [C(19)], 131.5 [C(16), C(18)], dark, reddish brown mixture was cooled to - 78° C. and 
167.0 [C(20)], non-protonated and vinylic carbons 10 this was added to a solution of 1.56 g (9.4 mmol) 4-




Methyl 4-Formylbenzoate (33) 
(31) 
period of one minute. The solution was stirred for 2 
minutes at - 78° C. and at room temperature for two 
more hours. The mixture changed from a reddish 15 
brown to a pale yellow color. After 2 hours, the reac-
tion mixture was filtered and the resulting solid was 
washed (anhydrous ether, 30 mL). The filtrate was 
concentrated to give a yellow oil. This yellow oil was 
20 kept overnight in refrigerator and yielded a yellow solid 
which was passed through 35 grams of silica gel [col-
(32) umn, (8X200 mm)]. The product was eluted with 400 
mL of hexane: ethylacetate (4:1); concentration of the 
eluent gave a viscous oil from which yellow solid was 
25 obtained at room temperature. The yellow solid was 
dissolved in a minimum amount of boiling absolute 
ethanol which gave fine pale yellow crystals [1.03 
grams (35.1%)] of nitrile 34: mp 134°-134.5° C.; IR 
(KBr) 2220-2240 cm-I (CN); IH NMR (DCCh) 61.80 
30 [s, 6H, (CH3)2C], 2.21 [s, 3H, CH3-C], 2.30 [m, 2H, 
CH2-C], 4.22 [m, 2H, CH2-O], 6.33 [s, lH, CH==C], 
6.80 [d, lH, H(8)], 7.21 [dd, lH, H(7)], 7.44 [d, lH, 
H(5)], 7.50 [d, 2H, H(15), H(19)], 7.90 [d, 2H, H(16), 
H(18)]; i3C NMR (DCCl3) ppm 17.8 [C(12)], 30.7 
35 [C(4)], 31.6 [C(9), C(lO)], 35.6 [C(3)], 63.2 [C(2)], 116.9 
[C(l3)], 119.2 [C(20)], 124.3 [C(7)], 124.6 [C(5)], 124.9 
[C(8)], 129.7 [C(16), C(18)], 131.9 [C(15), C(19)], non-
protonated and vinylic carbons [109.4, 131.6, 135.3, 
140.6, 153.6]; mass spectral data for C21H21NO: m/e 
(M+) 303.1623. Found: 303.1627. 
A 500-mL, three-necked, round bottom flask was 
eqipped with a teflon-coated stirring bar, soxlet extrac-
tor and condensor with drying tube at the top. The flask 
was charged with 10.0 g (66.6 mmol) of 4-formylben-
zoic acid, about 320 mL of absolute CH3OH and 0.1 mL 40 
of concentrated H2SO4. The soxlet extractor was filled 
with 3 A molecular sieve. After the solution was boiled 
for 48 hours, it was allowed to cool to room tempera-
ture and then was concentrated to a volume of about 50 
mL, diluted with an equal amount of water, and ex- 45 
tracted (ether 4 X 70 mL). The cqmbined organic layers 
were washed with saturated NaHCO3 solution (5 X 50 
mL), 0.1 NHCl (10X40 mL), H2O (2X50 mL), and 
saturated NaCl solution (2X50 mL). The resulting or-




tered and concentrated in ·vacuo. The white solid ob- (E)-4-[2-Methyl-2-(4,4-dimethyl-6-chromanyl)]benzyl 
tained was recrystallized (hexane) to give 6.3 grams Alcohol (35) 
(57.6%) of ester 33 mp 59.5°-60° C. [literature reports A solution of methyl (E)-4-[2-(3,4-dihydro-4,4-
590 -600 C.; see J.M. Landesberg, M.A. Slam, and M. 55 dimethyl-2H-1-benzopyran-6-yl)-1-propenyl]benzoate 
Mandel J. Org. Chem., 46, 5025 (1981)]; IR (KBr) 31 (0.29 g, 0.86 mmol) in anhydrous tetrahydrofuran (2 
1680-1740 cm-I (C=O); 1H NMR (DCCl3) 64.00 (s, mL) was added dropwise under N2 to a stirred suspen-
3H, ocw), 7.80=8.32 (m, 4H, Ar-H), 10.10 (s, lH, sion of LiAlH4 (0.04 g, 1.10 mmol) in dry THF. The 
CHO); C NMR (DCCl3)ppm 52-6 [OCH3], Ar-C mixture was heated at reflux for 8 hours and, after cool-
[129.6, 130.4, 135.2, 139.2], 166.0 [CO2 CH3], 191.~ 60 ing to room temperature, ethyl acetate (8 mL) was 
[CHO]; mass spectral data for C9Hs03: m/e (M+ ). added to destroy residual LiAlff4. The resulting mix-
164.0473. Found: 164.0472. ture was stirred for 5 minutes. The two layers were 
(33) 
separated, and the aqueous layer was washed (ether, 
2X25 mL). The combined organic layers were washed 
65 with 5% Na2CO3 (50 mL), H2O (25 mL), and brine (25 
mL). After drying (MgS04, 2 h), the organic solution 
was evaporated leaving a thick yellow oil. Chromatog-
raphy using a Chromatotron with a silica gel plate ( 4 
4,826,984 
28 27 
mm) and eluting with 80% hexane: ethyl acetate (200 
mL total) gave, after concentration, a viscous oil which 
solidified after refrigeration overnight. Dissolving this 
solid in minimum amount of boiling hexane produced, 
after cooling, 65 mg (25%) of the alcohol 35 as a white 5 
amorphous powder; mp 79° -80° C. IR (KBr) 3510-3060 
(O-H) cm-I. IH NMR (DCCl3) 61.18 [s, 6H, 
(H3C)2C], 1.86 [m, 2H, H(3)], 1.90 [s, lH, OH], 2.26 [s, 
3H, H(12)], 4.22 [m, 2H, OCH2CH3], 4.70 [s, 2H, 
H(20)], 6.76 [s, lH, CH=C(CH3)], 6.82 [d, J =9 Hz, lH, 10 
H(S)], 7.28 [dd, J =9 Hz, lH, H(7)], 7.38 [s, 4H, H(15), 
H(16), H(18), H(19)], 7.44 [d, J =3 Hz, lH, H(5)]. 13C 
NMR (DCCl3) ppm 17.56 [C(l2)], 30.70 [C(4)], 31-31 
[C(9), C(lO)], 37.66 [C(3)], 63.10 [C(2)], 65.18 [C(20)], 
116.70 [C(S)], 124.40 [C(5)], 124.8 [C(7)], 125.37 [C(13)]. 15 
There are other non-protonated and vinyl carbons 
which could not be distinguished. 131.22, 136.02, 
137.42, 138.70, 153.04: Mass spectral data for C21H24O2: 





In order to demonstrate and evaluate the biological 
activity of the heteroarotinoids according to the present 
invention, selected compounds were assayed either via 
analysis of the suppression of the 12-o-tetradeconoyl-
phorbol-13-acetate (TPA) induced synthesis of omi-
thine decarboxylase (ODC) in mouse skin or the induc-m/e (M+) 308.1776. Found: 308.1765. 
OH 
(35) 
20 tion of differentiation of human (HL-60) promylelo-
cytic cells. In the ODC assay, either 13-cis-retinoic acid 
or trans-retinoic acid was employed. The following 
Table summarizes the result of the ODC assays. 









0.00 ± 0.0 
0.90 ± 0.31 











17 0.1 ±0.o! 89% 
A solution of nitrite 34 (0.200 g, 0.66 mmol) in 25 mL 
of dry ether under N2 was stirred at room temperaure, 35 
and a solution of diisobutylaluminum hydride (DIBAL-
H) in hexane (l.0M, 1.34 mL, 1.34 mmol) was added 
dropwise. When the addition was complete (2 min), the 
mixture was allowed to boil with stirring from 38 hours 
and was allowed to cool to room temperature. The 40 
resulting solution was diluted with CH3OH (10 mL). 
Then dilute H2SO4 (5%, 25 mL) was added cautiously 
until the aqueous phase was acidic. This aqueous layer 
was washed with ether (2X25 mL). The combined 
45 organic phase and extract were washed with 5% NaH-
CO3 (2XS0 mL), water (SO mL), and finally with brine 
(25 mL). After drying (MgSO4, 30 min), the solution 
was evaporated to a viscous yellow oil. Chromatogra-
phy of. the oil was performed using silica gel (=12 50 
grams) through a vertical column (8 X 200 mm). Elution 
was effected with hexane: ethyl acetate (4:1, 200 mL). 
Concentration of the eluent gave a viscous oil which 
solidified upon standing in an ice bath for 2 hours. Solu-
tion of the solid in a minimum amount of hot hexane 55 
gave, upon cooling, 51 mg (26% of aldehyde 36 as a 
white crystalline material: mp 85° -86° C. IR (KBr) 2750 
(CH==O), 1700 (C==O) cm-I; IH NMR (DCCl3) 61.39 
[s, 6H, (H3C)2C]. 1.86 [m, 2H, H(3)], 2.29 [s, 3H, H(l2)], 
4.22 [m, 2H, OH2CH3], 6.77 [s, lH, CH=CH3], 6.81 [d, 60 
J=9 Hz, lH, H(S)], 7.26 [dd, J=9 Hz, J=3 Hz, lH, 
H(S)], 7.51 [d, J =9 Hz, 2H, H(lS), H(l7)], 7.87 [d, J =9 
Hz, 2H, H(16), H(18)], 10.0 [s, lH, CHO]; 13C NMR 
(DCCl3) ppm 17.88 [C(12)], 30.7 [C(4)], 31.65 
[C(9)C(10)], 37.60 [C(3)], 63.14 [C(2)], 116.8 [C(8)], 65 
124.56 [C(S)], 124.93 [C(7)], 129.61 [C(13)], 191.79 
[CHO], non-protonated and vinyl carbons: 129.67, 
131-39, 134.14, 135.50, 140.39, 145.08, 153.39; mass 
•nmol COz/30 min/mg protein 
Acetone 0.0 
Acetone+ TPA 0.0 
13-cis-retinoic 17 
acid+ TPA 
31 + TPA 
34 + TPA 
Acetone 
Acetone + TPA 
trans-retinoic 
acid+ TPA 
35 + TPA 
36 + TPA 













0.00 ± 0.0 
1.67 ± 0.14 Control 
0.14 ± 0.04 92 
0.95 ± 0.06 43 
1.77 ± 0.32 
0.00 ± 0.0 
5.3 ± 0.7 Control 
1.0 ± 0.1 81 
1.7 ± 0.1 68 
3.5 ± 0.2 34 
1.5 + 0.4 72 
OH 
In the screening tests of the Table, the selected reti-
noids in 0.2 ml of acetone were applied 1 hour before 
the application of 10 nmole ofTPA to the shaved backs 
of mice; the mice where then sacrificed for ODC assay 
S hours after TP A treatment. Epidermus was separated, 
homogenized, and centrifuged at 30,000 X g. Soluble 
epidermal ODC activity was assayed. The retinoids 
were evaluated in three independent experiments (3 
groups of mice with 3 mice per group) and the results 
from the experiments were normalized (% inhibition) 
for comparison. As seen from the data, the furanyl ester 
24 had the strongest activity while the chromanyl alco-
hol 35, ester 31 and aldehyde 36, were less active in 
inhibiting ODC induction by TPA. Under the same 
4,826,984 
30 29 
oxygen atom in the cyclohexyl ring of TTNPB is re-
sponsible for this decrease in activity,. In a related find-
ing, substitution of a sulfur atom at the same position in 
the cyclohexyl ring of the TTNPB results in a large 
decrease in biological activity measured either as the 
effectiveness in reversing keratinization in tracheas 
from vitamin A-deficient hamsters or in competing with 
retinoic acid for sites on the cellular retinoic acid-bind-
ing protein from the same tissue. Because the acid de-
rived from 34 and the sulfur-substituted TTNPB deriva-
tive have not been tested for biological activity in the 
conditions as used for the alcohol 24 and aldehyde 36, 
the furanyl ester 24 exhibited strong activity as com-
pared to the control. In experiments with 13-cis-retinoic 
acid as the standard, the relative activities of the reti-
noids in suppressing TP A induction of ODC were: 5 
13-cis-retinoic acid 31 > 34. In experiments with trans-
retinoic acid as a standard, the relative activities were: 
trans-retinoic acid > 24 > 35 > 36. Which standard is 
used appears to be relatively unimportant for determin-
ing activity in the assay, but the data presented in the 10 
Table identifies the standard for sake of clarity and 
accuracy of presentation. Thus, the presence of the 
heteroatom in these arotinoids has not eliminated bio-
logical activity. It is also clear that the acid in the simple 
esters are the most active regardless of whether sulfur 
oxygen is the heteroatom. Consequently, the nature of 
the terminus group is also important. 
15 same assay, the relative activity of these two retinoids is 
EXAMPLE XXIII 
In order to evaluate the efficacy of the heteroaroti- 20 
noids to induce HL-60 cell differentiation along the 
granulocytic maturation pathway, HL-60 cells were 
grown in a serum-free medium consisting of HRPMI 
1640 supplemented with 10 nM 4-(2-hydroxyethyl)-1-
piperazineethane sulfonic acid, 5 µ,g of insulin/mL, and 25 
5 µ,g of transferrin/mL. These mature cells, unlike the 
uninduced HL-60, produced superoxide anion when 
simulated with an appropriate agent, such as TP A. The 
ability of the individual cells to produce superoxide can 
be measured by incubating cells with the water-soluble 30 
yellow dye, nitroblue tetrazolium (NBT). NBT is re-
duced to a water-insoluble blue-black formazan by su-
peroxide. This formazan precipitate is associated with 
those cells that produce superoxide. Thus, the percent-
age of cells in a population that produce superoxide 35 
(NBT-positive cells) can be enumerated under a light 
microscope. 
The retinoids were dissolved in DMSO or ethanol 
and diluted into the culture medium so that the final 
concentration of the solvent did not exceed 0.1 %, a 40 
concentration that has no effect on differentiation. After 
incubation for 4 days at 37° C. in a humidified atmo-
sphere of 5% CO2 and air, the capacity of the cells to 
reduce NBT was determined. Viable cells (106) were 
harvested by centrifugation and suspended in 0.5 mL of 45 
RPMI 1640 containing 20% fetal bovine serum. This 
cell suspension was mixed with an equal volume of 
phosphate buffered saline containing 1 mg of NBT /mL 
and 200 mg of TP A/mL. The reaction mixture was 
incubated at 37° C. for 25 minutes, and the reaction was 50 
terminated by cooling in an ice water bath. Cytospin 
slides were prepared from a portion of this reaction 
mixture and stained with Wright-Giemsa. A minimum 
of 200 cells were counted under light microscopy to 
determine the percentage of cells with cell-associated 55 
formazan. 
The concentrations of retinoid effective in achieving 
a half-maximal response (EDso) for the esters 31, 24, 35, 
and the free acid 26 and that derived from 34, were all 
greater than 3 µ,M. At a concentration of 3 µ,M, both 31 60 
and acid derived from 34 induced approximately 15% 
of the cells to differentiate while 24 and 25 gave values 
of 3 to 5%, the same as the control. It has been reported 
previously that tetrahydrotetramethylnaphthalenyl-
propenylbenzoic acid (TTNPB) has an ED so of approx- 65 
imately 200 nM in the HL-60 differentiation assay. The 
findings in this study that acid derived from 34 has an 
EDso of < 3,000 nM indicates that the substitution of an 
not known. However, based on the relative activities in 
the present study, it is likely that the oxygen-substituted 
derivative would have a lower biological activity than 
the sulfur-substituted derivative. Thus, it can be con-
cluded that the heteroarotinoids examined display a 
range of activities in the ODC and HL-60 screens. The 
most significant activity was found in systems in which 
sulfur replaced the C(l) position in the cyclohexyl ring 
system, although the replacement by oxygen gave ex-
amples with only slightly less activity. 
Having thus described and exemplified the preferred 
embodiments with a certain degree of particularity, it is 
manifest that many changes can be made within the 
details of operation, operating parameters, and steps for 
synthesizing and using the heteroarotinoids according 
to the present invention without departing from the 
spirit and scope of this invention. Therefore, it is to be 
understood that the invention is not limited to the em-
bodiments set forth herein for purposes of exemplifica-
tion, but is to be limited only by the scope of the at-
tached claims, including the full range of equivalents to 
which each step thereof is entitled. 
We claim: 
1. A compound selected from the group character-
ized by the formulae: 





































































2. A compound selected from the group character-
ized by the formula: 
wherein Xis selected from 0, S, and S---+0, and wherein 
R is selected from H, CH3-, and C2H5. 
60 3. A compound according to claim 2 consisting essen-
tially of the trans isomer wherein X is S and R is C2H5. 
4. A compound according to claim 2 consisting essen-
tially of the trans isomer wherein X is O and R is C2H5. 
5. A compound according to claim 2 consisting essen-
65 tially of the trans isomer wherein X is S---+0 and R is 
C2H5. 
6. A compound according to claim 2 consisting essen-
tially of the trans isomer wherein X is O and R is H. 
4,826,984 
34 33 
7. A compound selected from the group character-







wherein Xis selected from 0, S, and S-+O, and wherein 
R is selected from H, CH3, and C2H5. 
8. A compound according to claim 7 consisting essen-
15 tially of the trans isomer wherein X is S and R is OH-
or OCH3. 
9. A compound according to claim 7 consisting essen-
tially of the trans isomer wherein X is S-+O and R is H 
or OCH3. 
20 10. A compound according to claim 7 consisting 
essentially of the trans isomer wherein X is O and R is 
OCH3. 
11. A compound according to claim 7 consisting 
essentially of the trans isomer wherein Xis Sand R is H. 
25 12. A compound according to claim 7 consisting 
essentially of the trans isomer wherein X is S and R is 
OCH3. 
13. A compound according to claim 7 consisting 
essentially of the trans isomer wherein X is O and R is 
30 H. 








UNITED STATES PATENT AND TRADEMARK OFFICE 





May 2, 1989 
BERLIN ET AL. 
It is certified that error appears in the above-identified patent and . that said Letters Patent 
is hereby corrected as shown below: 
Col. 34, line 15, change "OH- 11 
Col. 34, line 16, change 11 0CH3" 
Col. 34, line 19, change "OCH3 II 
Col. 34, line 22, change 11 0CH3 11 













Signed and Sealed this 
T"'enty-third Day of April, 1991 
HARRY F. MANBECK, JR. 
Commissioner of Parents and Trademarks 
